IL-4 blockers (Apogenix)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIL-4 blockers (Apogenix)
Drug Alias Nameprotein-based apoptosis sensitizer (Apogenix)APG-201
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterleukin-4 receptors inhibitors
TargetsInterleukin-4 receptors
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesApogenix Biotechnology AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A